|« Previous month||Next month »|
28-Jun-2012 - Bosch Packaging says it is now developing a big batch version of its new X-ray capsule inspection tech.
28-Jun-2012 - The FDA has sent a closeout to Cephazone Pharma after an inspection of changes made since last year’s warning letter.
28-Jun-2012 - Scientists have uncovered a new simple way to “clean” genotoxic impurities (GTIs) in drug ingredients by mixing the solution with contamination-eating scavengers.
27-Jun-2012 - PPMA is fearful that the Government of Pakistan’s recent call for more foreign investment in the local pharma sector will go unheard because the industry is already overcrowded.
27-Jun-2012 - in-PharmaTechnologist.com presents a roundup of academic drug delivery news, including Pfizer working with Chinese researchers.
27-Jun-2012 - Health Canada has warned of paclitaxel batches from Hospira that may have particles embedded in the vial or floating in the solution.
26-Jun-2012 - Sartorius Stedim says its new range of sterilising-grade filters can allow steam cleaning in dry conditions and minimises protein binding.
26-Jun-2012 - The FDA has accused Amylin of withholding cardiac safety information in its marketing application for an extended-release diabetes drug.
26-Jun-2012 - The EMA has updated its quality documents with sections on genotoxic impurities, residual solvents, and heavy metal catalyst residues.
25-Jun-2012 - in-PharmaTechnologist.com presents a very special round-up of the latest movers and shakers in the industry, including news from our very own Nick Taylor, as well as bulletins from BIA, Merrimack...
25-Jun-2012 - The EMA is advising manufacturers to simulate dropping a drug delivery device during development to test its robustness.
25-Jun-2012 - The manufacturing quality clampdown by regulators is a “significant risk” for Indian drugmakers, a credit rating agency said.
21-Jun-2012 - Drug regulators and the biomanufacturing industry need to embrace drug delivery via the skin to solve solubility problems with peptides and proteins, according to Across Barriers’ Udo Bock.
21-Jun-2012 - in-PharmaTechnologist.com presents its weekly round-up of the latest comings and goings in the pharma industry, including news from BioAlliance, Cangene and Sucampo.
21-Jun-2012 - The price of water and corporate agendas are driving pharmaceutical production plants to reuse and reclaim waste, Veolia said.
21-Jun-2012 - West Pharmaceutical Services has inked a deal with Amgen to evaluate its Crystal Zenith technology for drug containment.
20-Jun-2012 - New 'similar biologics' guidelines will curb the rising cost of innovation, attract overseas investment and ensure patients have access to drugs according to the Indian Government team which launched them...
20-Jun-2012 - Unilife has signed a seven-year contract to supply its Unifill prefilled syringe for use with a generic auto-immune drug.
20-Jun-2012 - Freeman Technology has added a new “intuitive” control system to its multi-purpose powder analysis system.
20-Jun-2012 - A risk-benefit assessment framework for new drugs is a must for Pharmas, a leading industry expert told attendees at BIO 2012 in Boston.
19-Jun-2012 - Safety, efficiency, innovation and single-use tech are the buzz words at Achema 2012 in Frankfurt.
19-Jun-2012 - DSM has signed an antibody contract manufacturing deal focused in its intensified cell culture process, XD.
19-Jun-2012 - HHS is investing $400m (€318m) to create centres to speed development and production of medical countermeasures.
18-Jun-2012 - ATMI has added helium integrity testing of bioprocess vessels in response to what it says is a boom in the single-use technology arena.
18-Jun-2012 - GE has told the EC the need to test how RFID affects biologic stability means it is too costly to use in anti-counterfeiting.
18-Jun-2012 - The US FDA has posted a closeout letter to an AkzoNobel Mexican API plant seven months after it warned the facility.
18-Jun-2012 - Ubichem has expanded its pharmaceutical ingredient capabilities through the opening of a 590,000 sq ft plant in Hungary.
14-Jun-2012 - Mettler Toledo is taking its ramped-up track and trace offering to the US in a bid to plug what it says is a sizeable gap in the market.
14-Jun-2012 - ProBioGen has launched a new pathway modulator for mammalian cell lines that it says improves protein production efficiency.
14-Jun-2012 - Biogen Idec expects the market for injectable MS drugs to shrink as patients choose more convenient delivery forms.
14-Jun-2012 - The Indian Government must better support modernisation efforts at small businesses to boost GMP compliance, a report found.
13-Jun-2012 - in-PharmaTechnologist.com presents its latest line-up of the new appointments within the industry, including news from Abbott, Trophos and the NIH.
13-Jun-2012 - Eli Lilly will use its drug delivery device capabilities to boost the competitiveness of its developmental basal insulins, the firm’s SVP said.
13-Jun-2012 - Bayer is trying to protect its manufacturing process for a chewable drug delivery dosage form with a US patent application.
13-Jun-2012 - Submitting a REMS (Risk Evaluation and Mitigation Strategies) proposal for risky drug developments could earn companies brownie points, according to Quintiles’ Ed Tabor.
12-Jun-2012 - German drug approval and pricing laws are prompting Pharmas to abandon the market says the EFPIA, which has called for ‘urgent action’ to protect innovation and access to medicines.
12-Jun-2012 - The CEO of Lycotec says its chocolate formulation of a liver-targeted oral compound has attracted interest from the NIH and FDA.
12-Jun-2012 - The FDA is proposing a warning to cover the “extremely remote risk” of viral disease spreading from drugs manufactured using albumin.
11-Jun-2012 - The upcoming tender for antiretroviral meds (ARVs) in South Africa will be opened up to more companies in a bid to tackle shortages, an insider told us.
11-Jun-2012 - Pall posted weaker than expected results after the switch to a new ERP system caused “self-inflicted disruption” of supply.
11-Jun-2012 - Biopharma firms can overcome a hurdle to ending drug shortages by having transparent talks with the FDA, an Agency official said.
07-Jun-2012 - The UK pharma manufacturing market is predicted to see a modest 2.7 per cent growth over the next five years largely due to pricing schemes set by the Government, according...
07-Jun-2012 - Milan head-quartered plant extract specialist, Indena, has been granted the ISO14001 certification for its Tours production site in France, marking the second for its five production sites.
07-Jun-2012 - The EMA has adopted a policy for handling GMP non-compliance information from other regulators or international organisations.
07-Jun-2012 - The US FDA has sent warning letters to eight biopharma companies for failing to register production facilities.
07-Jun-2012 - in-PharmaTechnologist.com presents a roundup of drug delivery news, including a FDA set back at Amylin and expansion at Particle Sciences.
06-Jun-2012 - Pfizer has confirmed 177 staff working for production facilities in Ireland will be cut.
06-Jun-2012 - in-PharmaTechnologist.com presents its latest weekly line-up of the new faces and places in the pharmaceutical industry, including news from MorphoSys, Pinnacle and Catabasis.
06-Jun-2012 - A bigger initial pay-out for REMS means long-term profitability for drugsmakers, says Quintiles Ed Tabor.
06-Jun-2012 - AMPAC is selling its aerospace business after deciding it lacked the “horsepower” to grow both it and the pharmaceutical unit.
06-Jun-2012 - A US appeals court has judged failure to report FDA Form 483s can mislead investors in its revival of a case against KV Pharmaceutical.
05-Jun-2012 - Schenck Accurate, Malvern, PSL and Sturtevant have teamed up to create a “unique” new turnkey isolated milling suite which they say will wipe out unnecessary waiting times for high potency (HP) drug...
05-Jun-2012 - Hydrogen peroxide could be the key to safer and more efficient vaccine production, according to researchers at Oregon Health & Science University.
05-Jun-2012 - The EMA has joined the FDA in proposing to accept different biosimilar formulations and closures in revised draft guidelines.
04-Jun-2012 - The new Generic Drugs User Fee Act (GDUFA) means a “level playing field” for drugmakers, according to SOCMA members.
04-Jun-2012 - The EMA has published draft guidelines on ensuring drug quality when producing APIs in transgenic animals.
04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.
|« Previous month||Next month »|